Network News

The Heidelberg and Mannheim University Hospitals consortium has taken first place in the Stern hospital rankings

The Heidelberg and Mannheim University Hospitals consortium has taken first place in the Stern hospital rankings

CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

PEPperPRINT Secures State Funding for Development of GlycoPlex Glycopeptide Array Platform

PEPperPRINT Secures State Funding for Development of GlycoPlex Glycopeptide Array Platform

Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector

Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector

Tracing environmental change through river microbiomes in Luxembourg 

Tracing environmental change through river microbiomes in Luxembourg 

Excellent doctoral training enters its second phase: Heidelberg University’s medical faculties are continuing a successful Research Training Group in the field of immunology

Excellent doctoral training enters its second phase: Heidelberg University’s medical faculties are continuing a successful Research Training Group in the field of immunology

Hummingbird Diagnostics to Present New Findings Linking Ribosome Quality Control Pathway to Liquid Biopsy Biomarkers for Lung Cancer at EACR

Hummingbird Diagnostics to Present New Findings Linking Ribosome Quality Control Pathway to Liquid Biopsy Biomarkers for Lung Cancer at EACR

Why pain persists long after injuries have healed

Why pain persists long after injuries have healed

Heidelberg-based development revolutionizes hepatitis D therapy worldwide: US Food and Drug Administration (FDA) approves hepatitis drug Hepcludex (bulevirtide)

Heidelberg-based development revolutionizes hepatitis D therapy worldwide: US Food and Drug Administration (FDA) approves hepatitis drug Hepcludex (bulevirtide)